Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam adjunctive therapy for GTC seizures
NCT01228747Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Percentage Change From the Combined Baseline in the Generalized Tonic-clonic Seizure Frequency Per Week Over the 28-week Treatment Period. Started Oct 2010; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01228747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228747.